Drug May Repair DNA at Earliest Stages of Alzheimer’s – And it’s Already Passed Safety Trials

A drug, that has previously been shown to be safe and tolerated by humans, reduces multiple disease-linked features of Alzheimer’s in a lab model of the disease, say neuroscientists in London. The team from King’s College has developed an approach that targets a key protein to tackle several features of Alzheimer’s disease at the same